EXi CEO, Grace McNamara attending our most recent panel discussion with Europe Active, discussing the digital consumer trends and inclusion strategies from the fitness industry.
EXi CEO Grace McNamara discussing social prescribing as we begin to emerge from the COVID-19 crisis, and how businesses can actively respond to the need for it, to benefit healthcare systems, businesses and the individual.
"Think of EXi being to digital therapeutics what iPod was to digital music. Unlike other digital fitness solutions, EXi is classified as a medical device in app form, prescribing low/moderate intensity programmes, designed with multiple conditions in mind."
"[EXi] are prescribing exercise in the same way as a doctor prescribes drugs, specifically for therapeutic purposes, to both help prevent and manage medical conditions."
Brian shares his passion with keeping people active and knows first hand the importance of physical activity and health. "My parents, who were both GPs, have always welcomed exercise to benefit people’s health & wellbeing. EXi is one such digital solution that gives people access to medically endorsed exercise prescription allowing them to achieve positive, long-term health benefits.”
Featured as the best home workout for mobility: “[EXi] is the app to turn to if mobility and rehabilitation from injury or illness are an issue…You can complete your daily exercise in one or more sessions a day and the app uses your smartphone camera (or smart watch) to track health metrics. A game-changer.”
“There is no known medication which produces the same wide ranging and potent effects as exercise”. EXi Co-founder Carron Manning highlights how taking control of your health through physical activity can boost resilience to COVID-19 and long-term health conditions.
EXi Co-Founder Carron Manning explains how the app has not only adapted to the challenges of the pandemic but created tailored exercise prescriptions specifically for those with COVID-19: “There is the ability to reduce risk of how the virus may affect a patient.”
EXi welcomes Grace McNamara as CEO. Grace had led Apple's health & fitness strategic initiatives, and will drive EXi's mission to reform digital health: “There is more opportunity to leverage technology [in healthcare], with the right evidence and right support.”
EXi is one of 20 companies selected for the Accelerator programme for digital solutions that have the highest potential to meet London’s NHS challenges. The Accelerator aims to speed up the adoption of technology in the NHS, relieving pressure on services and empowering patients to manage their health.
Research highlights the need to include prescribed exercise in the management of chronic health conditions. “EXi fills a huge void in the market for safe, effective support for the sedentary, older adults, and those with chronic health conditions who perhaps would like to exercise but don’t know where to start,” says EXi co-founder, Carron Manning.
“It’s become easier to pop a pill than get out and move. We have to go back to basics and remind ourselves that our bodies were designed to move. Drugs can never replicate the same profound physiological effects that exercise has on the body.” EXi Co-Founder Carron Manning discusses solutions to the state of the nation’s health.
The obesity crisis is one which government has been trying to tackle for decades. Now paired with the current pandemic, it is clearer than ever that a simple and effective solution is required. NHS-approved EXi could be an excellent start point for people as it provides a free, safe and simple solution to tackle obesity.
Keeping physically and mentally well during the coronavirus has been hard for many of us, but for those living with a long-standing health condition, it’s an even bigger challenge....
Copyright © 2021 iPrescribe Exercise Digital Ltd - All Rights Reserved.
iPrescribe Exercise Digital Ltd t/a EXI is registered in England and Wales No 11944017. We are a credit broker and only offer credit products from etika. iPrescribe Exercise Digital Ltd is authorised and regulated by the Financial Conduct Authority FRN 915460. Credit subject to age and status.